The updated Asia-Pacific consensus statement on the role of endoscopic management in malignant hilar biliary obstruction

Abstract

The first Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma were published in 2013. Since then, new evidence on the role of endoscopy for management of malignant hilar biliary obstruction (MHBO) has emerged. To update the recommendation, we reviewed the literature using a PICO (population/intervention/comparison/outcomes) framework and created consensus statements. The expert panel voted anonymously using the modified Delphi method and all final statements were evaluated for the quality of evidence and strength of recommendation. The important points with inadequate supporting evidence were classified as key concepts. There were seven statements and five key concepts that reached consensus. The statements and key concepts dealt with multiple aspects of endoscopy-based management in MHBO starting from diagnosis, strategies and options for biliary drainage, management of recurrent biliary obstruction, management of cholecystitis after biliary stenting, and adjunctive treatment before stenting. Although the recommendations may assist physicians in planning the treatment for MHBO patients, they should not replace the decision of a multidisciplinary team in the management of individual patients.

Keywords

Pancreatobiliary (ERCP/PTCD) - Strictures - ERC topics - Tissue diagnosis - Endoscopic ultrasonography - Biliary tract - Intervention EUS

Publication History

Received: 10 May 2024

Accepted: 15 July 2024

Accepted Manuscript online:
16 July 2024

Article published online:
16 September 2024

• References

• 1 Angsuwatcharakon P, Kulpatcharapong S, Moon JH. et al. Consensus guidelines on the role of cholangioscopy to diagnose indeterminate biliary stricture. HPB (Oxford) 2022; 24: 17-29
• 2 Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T. et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 2013; 28: 593-607
• 3 Guyatt GH, Oxman AD, Kunz R. et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400
• 4 Guyatt GH, Oxman AD, Vist GE. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
• 5 Balshem H, Helfand M, Schunemann HJ. et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-406
• 6 Dalkey N, Helmer O. An Experimental Application of the DELPHI Method to the Use of Experts. Management Science 1963; 9: 458-467
• 7 Tummala P, Munigala S, Eloubeidi MA. et al. Patients with obstructive jaundice and biliary stricture +/- mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. J Clin Gastroenterol 2013; 47: 532-537
• 8 Cadamuro M, Al-Taee A, Gonda TA. Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma. J Hepatol 2023; 78: 1063-1072
• 9 Yoon SB, Moon SH, Ko SW. et al. Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for Diagnosis of Bile Duct Cancer: A Meta-Analysis. Dig Dis Sci 2022; 67: 3284-3297
• 10 Kulpatcharapong S, Pittayanon R, Kerr SJ. et al. Diagnostic performance of digital and video cholangioscopes in patients with suspected malignant biliary strictures: a systematic review and meta-analysis. Surg Endosc 2022; 36: 2827-2841
• 11 Chaiteerakij R, Barr Fritcher EG, Angsuwatcharakon P. et al. Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients. Gastrointest Endosc 2016; 83: 1228-1235
• 12 Arechederra M, Rullán M, Amat I. et al. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut 2022; 71: 1141-1151
• 13 Singhi AD, Nikiforova MN, Chennat J. et al. Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures. Gut 2020; 69: 52-61
• 14 Mehrabi A, Khajeh E, Ghamarnejad O. et al. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. Eur J Radiol 2020; 125: 108897
• 15 Teng F, Tang YY, Dai JL. et al. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis. World J Surg Oncol 2020; 18: 174
• 16 Vienne A, Hobeika E, Gouya H. et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc 2010; 72: 728-735
• 17 Caillol F, Bories E, Zemmour C. et al. Palliative endoscopic drainage of malignant stenosis of biliary confluence: Efficiency of multiple drainage approach to drain a maximum of liver segments. United European Gastroenterol J 2019; 7: 52-59
• 18 Chen M, Wang L, Wang Y. et al. Risk factor analysis of post-ERCP cholangitis: A single-center experience. Hepatobiliary Pancreat Dis Int 2018; 17: 55-58
• 19 Rerknimitr R, Kongkam P, Kullavanijaya P. Outcome of self-expandable metallic stents in low-grade versus advanced hilar obstruction. J Gastroenterol Hepatol 2008; 23: 1695-1701
• 20 Rerknimitr R, Kladcharoen N, Mahachai V. et al. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J Clin Gastroenterol 2004; 38: 518-523
• 21 Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47: 354-362
• 22 Sud R, Puri R, Choudhary NS. et al. Air cholangiogram is not inferior to dye cholangiogram for malignant hilar biliary obstruction: a randomized study of efficacy and safety. Indian J Gastroenterol 2014; 33: 537-542
• 23 Zhang WH, Ding PP, Liu L. et al. CO(2) or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction. BMC Gastroenterol 2020; 20: 189
• 24 Kongkam P, Orprayoon T, Boonmee C. et al. ERCP plus endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage for malignant hilar biliary obstruction: a multicenter observational open-label study. Endoscopy 2021; 53: 55-62
• 25 Sawas T, Al Halabi S, Parsi MA. et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 2015; 82: 256-267 e257
• 26 Xia MX, Cai XB, Pan YL. et al. Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study. Gastrointest Endosc 2020; 91: 1117-1128 e1119
• 27 Kim JY, Lee SG, Kang D. et al. The Comparison of Endoscopic Biliary Drainage in Malignant Hilar Obstruction by Cholangiocarcinoma: Bilateral Metal Stents versus Multiple Plastic Stents. Gut Liver 2021; 15: 922-929
• 28 Jiang Y, Zeng Z, Zeng J. et al. Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis. Front Oncol 2021; 11: 736113
• 29 Ottaiano A, Santorsola M, Diana A. et al. Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study. Cancer Med 2024; 13: e6892
• 30 Al Nakshabandi A, Ali FS, Albustami I. et al. Biliary Drainage in Hilar and Perihilar Cholangiocarcinoma; 25-Year Experience at a Tertiary Cancer Center. Gastrointest Endosc 2023;
• 31 Lee TH, Moon JH, Choi JH. et al. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc 2019; 90: 222-230
• 32 Cao Q, Sun L, Li ZQ. et al. Bilateral stenting for hilar biliary obstruction: a meta-analysis of side-by-side versus stent-in-stent. Minim Invasive Ther Allied Technol 2022; 31: 525-530
• 33 Ridtitid W, Rerknimitr R, Janchai A. et al. Outcome of second interventions for occluded metallic stents in patients with malignant biliary obstruction. Surg Endosc 2010; 24: 2216-2220
• 34 Okuno M, Mukai T, Iwashita T. et al. Evaluation of endoscopic reintervention for self-expandable metallic stent obstruction after stent-in-stent placement for malignant hilar biliary obstruction. J Hepatobiliary Pancreat Sci 2019; 26: 211-218
• 35 Kitamura H, Hijioka S, Nagashio Y. et al. Use of endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention after the placement of multiple metallic stents for malignant hilar biliary obstruction. J Hepatobiliary Pancreat Sci 2022; 29: 404-414
• 36 Launois B, Reding R, Lebeau G. et al. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000; 7: 128-134
• 37 Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol 2006; 4: 269-273
• 38 Liang XY, Li W, Liu F. et al. A Retrospective Study of Biliary Drainage Strategies for Patients with Malignant Hilar Biliary Strictures. Cancer Manag Res 2021; 13: 4767-4776
• 39 Wang L, Lin N, Xin F. et al. A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction. World J Surg Oncol 2019; 17: 116
• 40 Robson PC, Heffernan N, Gonen M. et al. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol 2010; 17: 2303-2311
• 41 Neal CP, Thomasset SC, Bools D. et al. Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome. Surg Endosc 2010; 24: 423-431
• 42 Pausawasdi N, Termsinsuk P, Charatcharoenwitthaya P. et al. Development and validation of a risk score for predicting clinical success after endobiliary stenting for malignant biliary obstruction. PLoS One 2022; 17: e0272918
• 43 Termsinsuk P, Charatcharoenwitthaya P, Pausawasdi N. Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction. Front Oncol 2022; 12: 922386
• 44 Ogura T, Higuchi K. Endoscopic Ultrasound-Guided Hepaticogastrostomy: Technical Review and Tips to Prevent Adverse Events. Gut Liver 2021; 15: 196-205
• 45 Ogura T, Sano T, Onda S. et al. Endoscopic ultrasound-guided biliary drainage for right hepatic bile duct obstruction: novel technical tips. Endoscopy 2015; 47: 72-75
• 46 Ma KW, So H, Cho DH. et al. Durability and outcome of endoscopic ultrasound-guided hepaticoduodenostomy using a fully covered metal stent for segregated right intrahepatic duct dilatation. Journal of Gastroenterology and Hepatology 2020; 35: 1753-1760
• 47 Sekine M, Hashimoto Y, Shibuki T. et al. A retrospective multicenter study comparing the punctures to B2 and B3 in endoscopic ultrasound–guided hepaticogastrostomy. DEN Open 2023; 3: e201
• 48 Umeda J, Itoi T, Tsuchiya T. et al. A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study (with videos). Gastrointest Endosc 2015; 82: 390-396.e392
• 49 Park SW, Lee SS. Which Are the Most Suitable Stents for Interventional Endoscopic Ultrasound?. J Clin Med 2020; 9
• 50 Shibuki T, Okumura K, Sekine M. et al. Covered self-expandable metallic stents versus plastic stents for endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction. Clin Endosc 2023; 56: 802-811
• 51 Leung Ki EL, Napoleon B. EUS-specific stents: Available designs and probable lacunae. Endosc Ultrasound 2019; 8: S17-s27
• 52 Ogura T, Higuchi K. Technical tips for endoscopic ultrasound-guided hepaticogastrostomy. World J Gastroenterol 2016; 22: 3945-3951
• 53 Cho DH, Lee SS, Oh D. et al. Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos). Gastrointest Endosc 2017; 85: 1067-1075
• 54 Lee J, Han SY, Baek D. et al. Risk Factors for Early- and Late-Onset Cholecystitis after Y-Configured Metal Stent Placement in Patients with Malignant Hilar Biliary Obstruction: A Single-Center Study. Journal of Clinical Medicine 2023; 12: 4354
• 55 Isayama H, Kawabe T, Nakai Y. et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol 2006; 4: 1148-1153
• 56 Kozakai F, Kanno Y, Ito K. et al. Endoscopic Ultrasonography-Guided Gallbladder Drainage as a Treatment Option for Acute Cholecystitis after Metal Stent Placement in Malignant Biliary Strictures. Clin Endosc 2019; 52: 262-268
• 57 Lu Y, Liu L, Wu JC. et al. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis. Clin Res Hepatol Gastroenterol 2015; 39: 718-724
• 58 Dolak W, Schwaighofer H, Hellmich B. et al. Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications. United European Gastroenterol J 2017; 5: 104-110
• 59 Schmidt A, Bloechinger M, Weber A. et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J 2016; 4: 570-579
• 60 Kang H, Han SY, Cho JH. et al. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial. J Hepatobiliary Pancreat Sci 2022; 29: 469-478
• 61 Oh D, Chong J, Song TJ. et al. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction. J Gastroenterol Hepatol 2022; 37: 2083-2090